Steven W. King
2012
In 2012, Steven W. King earned a total compensation of $1.2M as President and Chief Executive Officer at Peregrine Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $257,400 |
|---|---|
| Option Awards | $441,119 |
| Salary | $428,250 |
| Other | $33,784 |
| Total | $1,160,553 |
King received $441.1K in option awards, accounting for 38% of the total pay in 2012.
King also received $257.4K in non-equity incentive plan, $428.3K in salary and $33.8K in other compensation.
Rankings
In 2012, Steven W. King's compensation ranked 5,553rd out of 11,487 executives tracked by ExecPay. In other words, King earned more than 51.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,553 out of 11,487 | 52nd |
Division Manufacturing | 1,959 out of 4,253 | 54th |
Major group Chemicals And Allied Products | 474 out of 1,198 | 60th |
Industry group Drugs | 316 out of 920 | 66th |
Industry Pharmaceutical Preparations | 247 out of 700 | 65th |
Source: SEC filing on August 28, 2014.
King's colleagues
We found four more compensation records of executives who worked with Steven W. King at Peregrine Pharmaceuticals in 2012.
2012
Jeffrey Masten
Peregrine Pharmaceuticals
Former Vice President, Quality
2012
Paul Lytle
Peregrine Pharmaceuticals
Chief Financial Officer
2012
Joseph Shan
Peregrine Pharmaceuticals
Vice President, Clinical & Regulatory Affairs
2012
Shelley Fussey
Peregrine Pharmaceuticals